Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
C4 Therapeutics revenue
C4 Therapeutics's revenue is $35.6 million.
What is C4 Therapeutics's revenue?
- C4 Therapeutics's revenue growth from 2019 to 2024 is 66.43%.
- C4 Therapeutics has 300 employees, and the revenue per employee ratio is $118,613.
- C4 Therapeutics's peak quarterly revenue was $20.1M in 2021(q4).
- C4 Therapeutics peak revenue was $45.8M in 2021.
- C4 Therapeutics annual revenue for 2023 was 20.8M, -33.25% growth from 2022.
- C4 Therapeutics annual revenue for 2024 was 35.6M, 71.44% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
C4 Therapeutics historical revenue
C4 Therapeutics's peak revenue was $45.8M in 2021. The peak quarterly revenue was $20.1M in 2021(q4).
C4 Therapeutics's revenue increased from $21.4m in 2019 to $35.6M currently. That's a 66.43% change in annual revenue.
C4 Therapeutics annual revenue
C4 Therapeutics annual revenue over time
| Fiscal year / year | C4 Therapeutics revenue |
|---|---|
| 2019 | $21.4M |
| 2020 | $33.2M |
| 2021 | $45.8M |
| 2022 | $31.1M |
| 2023 | $20.8M |
| 2024 | $35.6M |
Rate C4 Therapeutics' financial transparency
C4 Therapeutics annual growth
C4 Therapeutics saw the greatest revenue growth in 2020, when revenue increased by 55.25%.
C4 Therapeutics had the lowest revenue growth in 2022, when revenue changed by -32.08%.
C4 Therapeutics annual growth rate over time
| Year | C4 Therapeutics growth |
|---|---|
| 2020 | 55%↑ |
| 2021 | 38%↑ |
| 2022 | -32%↓ |
| 2023 | -33%↓ |
| 2024 | 71%↑ |
C4 Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
C4 Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $8.4M | $8.3M |
| 2021 | $7.4M | $9.8M | $8.5M | $20.1M |
| 2022 | $7.7M | $13.8M | $6.8M | $2.9M |
| 2023 | $3.8M | $2.7M | $11.1M | $3.3M |
| 2024 | $3.0M | $12.0M | $15.4M | $5.2M |
C4 Therapeutics jobs nearby
Do you work at C4 Therapeutics?
Is C4 Therapeutics transparent about its revenue structure?
C4 Therapeutics financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 300 |
| Date Founded | 2015 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $35.6M |
| Net Income | -$128,175,000 |
| Tax Rate | -0.0% |
| Total Assets | $430,840,000 |
| Ticker | CCCC |
C4 Therapeutics jobs you might like
C4 Therapeutics financing
C4 Therapeutics received early financing of $73.0M on 2016-01-07.
| Series | Round size | Date |
|---|---|---|
| Series A | $73M | 01/2016 |
| Series B | $150M | 06/2020 |
| Debt Financing | $20M | 06/2020 |
| Post Ipo Equity | $180.8M | 06/2021 |
C4 Therapeutics investors
| Investors | Security type |
|---|---|
| Cobro Ventures Inc | Series A |
| EG Capital Group | Series A |
| Novartis | Series A |
| Roche | Series A |
| Cormorant Asset Management | Series A |
| Cobro Ventures Inc | Series B |
| RTW INVESTMENTS LP | Series B |
| Logos Capital | Series B |
| Yonjin Venture | Series B |
| 3E Bioventures Capital | Series B |
| Bain Capital Life Sciences | Series B |
| Mizuho Securities Principal Investment | Series B |
| Sphera Funds Management | Series B |
| Adage Capital Management | Series B |
| Nextech Invest | Series B |
| HBM Healthcare Investments AG | Series B |
| Lightchain | Series B |
| Perceptive Advisors | Series B |
| Janus Henderson Investors | Series B |
| Taiwania Capital | Series B |
| RA Capital Management | Series B |
| T. Rowe Price | Series B |
| Axil Capital | Series B |
| Commodore Capital, LP | Series B |
| Perceptive Advisors | Debt Financing |
C4 Therapeutics competitors
C4 Therapeutics's top competitor, Arvinas Inc., earned an annual revenue of $263.4M.
C4 Therapeutics's smallest competitor is Redesign Science with revenue of $110.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Sutro Biopharma | - | $62.0M | 160 | - |
| Cognition Therapeutics | - | $19.5M | 30 | - |
| Nurix | - | $54.5M | 103 | - |
| Kezar Life Sciences | - | $7.0M | 20 | - |
| eFFECTOR Therapeutics | - | $42.0M | 24 | - |
| Arvinas Inc. | - | $263.4M | 83 | - |
| Arcellx | - | $107.9M | 1 | - |
| Redesign Science | - | $110,000 | 7 | - |
| Chaperone Therapeutics | - | $690,000 | 30 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
C4 Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of C4 Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about C4 Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at C4 Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by C4 Therapeutics. The data presented on this page does not represent the view of C4 Therapeutics and its employees or that of Zippia.
C4 Therapeutics may also be known as or be related to C4 THERAPEUTICS, INC., C4 Therapeutics and C4 Therapeutics, Inc.